580 related articles for article (PubMed ID: 12865175)
21. Clinical and dosimetric predictors of radiation pneumonitis in early-stage lung cancer treated with Stereotactic Ablative radiotherapy (SABR) - An analysis of UK's largest cohort of lung SABR patients.
Saha A; Beasley M; Hatton N; Dickinson P; Franks K; Clarke K; Jain P; Teo M; Murray P; Lilley J
Radiother Oncol; 2021 Mar; 156():153-159. PubMed ID: 33333139
[TBL] [Abstract][Full Text] [Related]
22. Ipsilateral lung dose as a correlative measure for radiation pneumonitis in patients treated with definitive concurrent radiochemotherapy.
Kirakli EK; Erdem S; Susam S; Erim E
J Cancer Res Ther; 2023; 19(5):1153-1159. PubMed ID: 37787278
[TBL] [Abstract][Full Text] [Related]
23. Acute radiation pneumonitis after conformational radiotherapy for nonsmall cell lung cancer: clinical, dosimetric, and associated-treatment risk factors.
Leprieur EG; Fernandez D; Chatellier G; Klotz S; Giraud P; Durdux C
J Cancer Res Ther; 2013; 9(3):447-51. PubMed ID: 24125981
[TBL] [Abstract][Full Text] [Related]
24. [Non-small cell lung cancer: risk factors of radiation pneumonitis].
Giroux Leprieur E; Fernandez D; Chatellier G; Klotz S; Giraud P; Durdux C
Cancer Radiother; 2012; 16(4):257-62. PubMed ID: 22748977
[TBL] [Abstract][Full Text] [Related]
25. Prediction of radiation pneumonitis by dose - volume histogram parameters in lung cancer--a systematic review.
Rodrigues G; Lock M; D'Souza D; Yu E; Van Dyk J
Radiother Oncol; 2004 May; 71(2):127-38. PubMed ID: 15110445
[TBL] [Abstract][Full Text] [Related]
26. Prediction of radiation pneumonitis following high-dose thoracic radiation therapy by 3 Gy/fraction for non-small cell lung cancer: analysis of clinical and dosimetric factors.
Oh D; Ahn YC; Park HC; Lim DH; Han Y
Jpn J Clin Oncol; 2009 Mar; 39(3):151-7. PubMed ID: 19193653
[TBL] [Abstract][Full Text] [Related]
27. Study of the predictors for radiation pneumonitis in patient with non-small cell lung cancer received radiotherapy after pneumonectomy.
Yu JH; Wang CL; Liu Y; Wang JM; Lv CX; Liu J; Zhang Q; Fu XL; Cai XW
Cancer Radiother; 2021 Jun; 25(4):323-329. PubMed ID: 33446419
[TBL] [Abstract][Full Text] [Related]
28. Severe COPD is correlated with mild radiation pneumonitis following stereotactic body radiotherapy.
Takeda A; Kunieda E; Ohashi T; Aoki Y; Oku Y; Enomoto T; Nomura K; Sugiura M
Chest; 2012 Apr; 141(4):858-866. PubMed ID: 21885726
[TBL] [Abstract][Full Text] [Related]
29. Significance of plasma transforming growth factor-beta levels in radiotherapy for non-small-cell lung cancer.
De Jaeger K; Seppenwoolde Y; Kampinga HH; Boersma LJ; Belderbos JS; Lebesque JV
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1378-87. PubMed ID: 15050313
[TBL] [Abstract][Full Text] [Related]
30. A study of ethnic differences in TGFβ1 gene polymorphisms and effects on the risk of radiation pneumonitis in non-small-cell lung cancer.
Niu X; Li H; Chen Z; Liu Y; Kan M; Zhou D; Li Z; Ye X; Shen S; Lv C; Lu S
J Thorac Oncol; 2012 Nov; 7(11):1668-75. PubMed ID: 23059779
[TBL] [Abstract][Full Text] [Related]
31. Dose-volume factors predicting radiation pneumonitis in patients receiving salvage radiotherapy for postlobectomy locoregional recurrent non-small-cell lung cancer.
Uno T; Isobe K; Kawakami H; Ueno N; Kawata T; Yamamoto S; Sekine Y; Iyoda A; Iizasa T; Fujisawa T; Shigematsu N; Ito H
Int J Clin Oncol; 2006 Feb; 11(1):55-9. PubMed ID: 16508730
[TBL] [Abstract][Full Text] [Related]
32. Decreased risk of radiation pneumonitis with incidental concurrent use of angiotensin-converting enzyme inhibitors and thoracic radiation therapy.
Kharofa J; Cohen EP; Tomic R; Xiang Q; Gore E
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):238-43. PubMed ID: 22300564
[TBL] [Abstract][Full Text] [Related]
33. Analysis of clinical and dosimetric factors associated with severe acute radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent chemotherapy and intensity-modulated radiotherapy.
Shi A; Zhu G; Wu H; Yu R; Li F; Xu B
Radiat Oncol; 2010 May; 5():35. PubMed ID: 20462424
[TBL] [Abstract][Full Text] [Related]
34. Correlation of dosimetric factors with the development of symptomatic radiation pneumonitis in stereotactic body radiotherapy.
Ryckman JM; Baine M; Carmicheal J; Osayande F; Sleightholm R; Samson K; Zheng D; Zhen W; Lin C; Zhang C
Radiat Oncol; 2020 Feb; 15(1):33. PubMed ID: 32054487
[TBL] [Abstract][Full Text] [Related]
35. Dose-volume parameters predict radiation pneumonitis after induction chemoradiotherapy followed by surgery for non-small cell lung cancer: a retrospective analysis.
Katsui K; Ogata T; Watanabe K; Katayama N; Soh J; Kuroda M; Kiura K; Maeda Y; Toyooka S; Kanazawa S
BMC Cancer; 2019 Nov; 19(1):1144. PubMed ID: 31771538
[TBL] [Abstract][Full Text] [Related]
36. Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy.
Yorke ED; Jackson A; Rosenzweig KE; Merrick SA; Gabrys D; Venkatraman ES; Burman CM; Leibel SA; Ling CC
Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):329-39. PubMed ID: 12243805
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the radiation pneumonia development risk in lung cancer cases.
Yilmaz S; Adas YG; Hicsonmez A; Andrieu MN; Akyurek S; Gokce SC
Asian Pac J Cancer Prev; 2014; 15(17):7371-5. PubMed ID: 25227844
[TBL] [Abstract][Full Text] [Related]
38. The risk and predictors for severe radiation pneumonitis in lung cancer patients treated with thoracic reirradiation.
Ren C; Ji T; Liu T; Dang J; Li G
Radiat Oncol; 2018 Apr; 13(1):69. PubMed ID: 29661254
[TBL] [Abstract][Full Text] [Related]
39. [Importance of dosimetric factors predicting radiation toxicity in lung cancer treatment].
Letautiene SR; Valuckas KP
Medicina (Kaunas); 2006; 42(4):314-20. PubMed ID: 16687903
[TBL] [Abstract][Full Text] [Related]
40. Predicting radiation pneumonitis in locally advanced stage II-III non-small cell lung cancer using machine learning.
Luna JM; Chao HH; Diffenderfer ES; Valdes G; Chinniah C; Ma G; Cengel KA; Solberg TD; Berman AT; Simone CB
Radiother Oncol; 2019 Apr; 133():106-112. PubMed ID: 30935565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
